Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Maharashtra FDA cancels Johnson & Johnson baby powder manufacturing license

by AIP Online Bureau | Sep 17, 2022 | Health, Indian News, Policy, Regulation

The press note said that the samples of Johnson’s Baby Powder were declared “Not of Standard Quality”. FDA Maharashtra had taken the samples of Johnson’s Baby Powder at Pune and Nashik for quality check purposes Mumbai: Food & Drugs...
Next Entries »

Recent Posts

  • India’s Cloudburst Challenges:Insurance gaps & Future safeguards
  • Aerospace Industry: Facing strong supply chain headwinds
  • Tesla’s European regulator says door safety a ‘Key Priority’
  • UK sanctions Russia’s Lukoil and Rosneft, targets shadow fleet
  • Jio Insurance Broking earns Rs 347 cr in premiums, issues 2.9 lakh policies in Q2FY26

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy